4118 on Tokyo Stock Exchange

Kaneka Corporation

Logo: Kaneka Corporation , Shin Matsunaga, Public domain, via Wikimedia Commons5

Japanese chemical manufacturing company

Kaneka Corporation (株式会社カネカ, Kabushiki-gaisha Kaneka) is a Japanese international chemical manufacturing company based in Osaka. The company was founded in 1949 and produces chemical products such as functional resin, foam resin, and synthetic fibers. The company was also engaged in the medical equipment business.3 Its shares trade on Tokyo Stock Exchange under the symbol 4118.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1949Founded1

Compare with another stock.

  • Ticker4118 on Tokyo Stock Exchange1
  • Industrychemistry1
  • HeadquartersNakanoshima1
  • Websitewww.kaneka.co.jp
  • Legal formkabushiki gaisha1
  • Incorporated inJapan6
  • Business address2-3-18, Nakanoshima, Kita-Ku, Osaka, M0 530-82886
  • LEI529900FWWCF6RY313R164
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered address北区中之島2丁目3番18号, 530-8288 大阪市, Japan4
  • Registered withNational Tax Agency, 81200010596284

Kaneka Corporation (株式会社カネカ, Kabushiki-gaisha Kaneka) is a Japanese international chemical manufacturing company based in Osaka. The company was founded in 1949 and produces chemical products such as functional resin, foam resin, and synthetic fibers.3

Corporate structure

Kaneka Corporation sits at the top of its group. 6 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Kaneka Corporation 大阪市, Japan
    • Cemedine Subsidiary · Ōsaki, Japan
    • Kaneka (United States) Subsidiary · Pasadena, United States
    • Kaneka Belgium Subsidiary · Westerlo, Belgium
    • Kaneka Europe Holding Company Subsidiary · Zaventem, Belgium
      • AB-BIOTICS S.A. Subsidiary · Sant Cugat del Vallès, Spain

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

The story

In 1949, the company was founded by separating from the Kanegafuchi Spinning Company, Ltd. with capital of 200 million yen. The company started with developing and producing vinyl chloride named "Kanevinyl". In 1950, the Osaka "Kanevinyl" plant was completed and the mass production of PVC wire covering started in Sakamoto factory. Year later, the company developed vinyl chloride resin type "Kanebirakku" and started production in Osaka factory. In 1953, in addition to the margarine production in Takasagokogyosho, the company started production of a soft vinyl chloride compound "Kanevinyl". In 1957, the company started the production of acrylic synthetic fiber named "Kanekalon".

In 1961, the company developed and marketed "Belco" for Fats and Oils, Ltd. and started the production in Takasago, Hyōgo. In 1965, the company developed expandable styrene-acrylonitrile resin named "Kanepearl". In 1966, Osaka factory developed the acrylonitrile butadiene styrene (ABS RESIN). In 1967, the company developed vinyl chloride resin paste named "Kanevinyl paste", which began producing in Osaka factory. In 1968, the company established offices in Europe and New York. Production of extruded polystyrene foam board named "Kanelite Foam" began in Kaneka Belgium.

In 1971, Kaneka Americas founded "Kanepearl" plant. In 1972, the company developed polystyrene paper, while development and commercialization of production for flame-retardant ABS resin "Enpurekkusu" started in Osaka factory. In 1979, Kaneka Singapore was founded. The production of modified silicone polymer named "Kaneka MS polymer" started in Kanepearl, now Kaneka Ken.

In 1980, the company marketed reaction intermediate HPG. In 1983, the company developed and marketed AMMPA Kaneka, intermediate for antihypertensive drug, as well as acrylic silicone polymer, Kaneka Gemlac. In 1985, the company developed and marketed polypropylene foam by using bead method. In 1986, the company developed and marketed plasmapheresis system. In 1989, the company developed modified PET resin named "Kaneka Hyperite".

In 1991, the company developed and marketed "Selesorb", a selective adsorption column for systemic lupus erythematosus. In 1993, the company established Nantong Sunrise Worsted Spinning Co., Ltd. as a joint venture with Kyusyu Kanekalon Co., Ltd. Kanematsu Corporation, and Toyobo Co., Ltd. In 1997, the company established Kaneka High-Tech Materials, Inc. to succeed the apical operations of Allied-Apical Company, Inc.

In 2000, the company acquired ISO 14001 certificate for its four plants located in Japan. In the same year, new Eperan factory in Michigan for Kaneka Texas Corporation was completed. The company also received ISO 9001 certificate for all related company divisions involved in making Kanelite Foam. In the same year, the company developed word's first non-fluorocarbon, non-halogen foaming agent type Kanelite Foam, the Type 3 insulation panel. In 2003, the company developed an imide film capable of forming a three-dimensional optical waveguide with a laser. In 2005, the company developed an industry's first acryl grafted vinyl chloride copolymer named "PRICTMER". One year later, in 2006, the company industrialized the world's first telechelic polyacrylate. In the same year, they developed a new injection molding resin by applying proprietary nanocomposite technology and developed toughness-enhancing master batches for epoxy resin. In 2008, the company developed a new resin with high mechanical strength and high light resistance named "ILLUMIKA", and developed the world's most advanced high thermal conductive graphite sheet, named Graphinity.

In 2010, the company developed new thermally conductive plastics with electric insulating properties, and the first dual UV/moisture-curing adhesive, together with ChemTech. In the same year, the company formed a capital alliance with the Belgian biotechnology company Eurogentec. In 2011, the company developed the first completely bio-based polymer with soft and heat-resistant properties, as well as a new thermosetting imide resin for a carbon-fiber-reinforced composite material with high heat resistance. In 2012, the company established Kaneka Asia Co., Ltd., an Asia regional umbrella hub based in Shanghai, China, as well as the Kaneka Americas Holding, Inc., an America regional umbrella hub based in Texas, United States. In 2013, the company established Kaneka South America Representative Ltd. and Kaneka Foods Indonesia. In the same year the company founded Kaneka US Material Research Center Facility, in partnership with Texas A&M University.

From Wikipedia’s article on Kaneka Corporation, shared under CC BY-SA 4.0.7

Products and brands

Bio-pharmaceutical research and development support

On March 6, 2015, the United States Food and Drug Administration authorized use of Lixelle Beta 2-microglobulin Apheresis Column, the first device to treat Haemodialysis-associated amyloidosis (DRA) developed and produced by Kaneka Corporation. The Lixelle Column system is used for helping patient to eliminate agents that cause inflammation. The system is used in treatment of HIV, arthritis, cholesterol management and ulcerative colitis.

From Wikipedia’s article on Kaneka Corporation, shared under CC BY-SA 4.0.7

Subsidiaries and ownership

Subsidiaries

From Wikidata.1

Timeline

  1. Oct 31, 1949Went public Listed on Tokyo Stock Exchange1
  2. 1949Founded Founded1

Filings

3 filings to the SEC since October 2021: 3 other. The latest 3:

  1. May 31, 2022CB/A EDGAR
  2. May 12, 2022F-X EDGAR
  3. May 12, 2022CB EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Kaneka Corporation is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARKANEKA Corp2
  • CIK0001921449
  • Employer ID (EIN)13-35568342
  • Incorporated inJapan2
  • Fiscal year endsMarch 312
  • Business address2-3-18, Nakanoshima, Kita-Ku, Osaka, M0 530-82882
  • Mailing address1-12-32, Akasaka, Minato-Ku, Tokyo, M0 107-60282
  • Phone81-80-9944-78542
  • On EDGAR sinceMay 12, 20222
  • Filings3 in all: CB (1), CB/A (1), F-X (1)2